Home › Funds › Y-Intercept (Hong Kong) Ltd › REGN

Y-Intercept (Hong Kong) Ltd position in REGN

REGENERON PHARMACEUTICALS · Health Care

Y-Intercept (Hong Kong) Ltd reported holding 25,842 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$19.6M, representing 0.43% of its reported portfolio and ranking #18 among its reported holdings. Y-Intercept (Hong Kong) Ltd has disclosed REGN holdings in 9 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)25.84K sh
Reported value held$19.60M
Portfolio Weight0.43%
First reportedQ4 2023
Last changeAdd
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How Y-Intercept (Hong Kong) Ltd's REGN position evolved

Y-Intercept (Hong Kong) Ltd first disclosed a stake in REGN in Q4 2023 at 3,185 shares (US$2.8M). The position peaked in Q3 2026 at 25,842 shares, worth US$19.6M. Across 9 filings, Y-Intercept (Hong Kong) Ltd increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 25,842 shares valued at US$19.6M — an increase of 22,644 shares quarter over quarter.. Notable position changes include a 259% increase in Q2 2025 (shares rose 8% over the following quarter), a 70% trim in Q3 2025 (shares rose 36% over the following quarter), a 708% increase in Q3 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 3.19K $2.80M New
Q1 2024 1.97K $1.89M Reduce
Q3 2024 9.43K $9.91M New
Q4 2024 11.53K $8.21M Add
Q1 2025 9.70K $6.15M Reduce
Q2 2025 34.87K $18.31M Add
Q3 2025 10.32K $5.80M Reduce
Q2 2026 3.20K $1.99M New
Q3 2026 25.84K $19.60M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Y-Intercept (Hong Kong) Ltd held REGN?

Y-Intercept (Hong Kong) Ltd has disclosed REGN holdings in 9 of the last 12 reported quarters, going back to Q4 2023.

What is Y-Intercept (Hong Kong) Ltd's current position in REGN?

As of Q3 2026, Y-Intercept (Hong Kong) Ltd holds 25.84K shares of REGN (REGENERON PHARMACEUTICALS), valued at $19.60M, representing 0.43% of its reported portfolio and ranking #18.

Has Y-Intercept (Hong Kong) Ltd been buying or selling REGN?

In the latest 13F filing (Q3 2026), Y-Intercept (Hong Kong) Ltd increased its position in REGN. The position peaked in Q3 2026 at 25.84K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.